Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 7, 2015, Pages 1041-1047

  Chielle, Eduardo Ottobelli ^a,b   Bonfanti, Gabriela ^a   De Bona, Karine Santos ^a   Moresco, Rafael Noal ^a   Moretto, Maria Beatriz ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b UNOESC   (Brazil)

Author keywords

Adenosine deaminase; dipeptidyl peptidase IV; lipid peroxidation; obesity; saliva

Indexed keywords

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE IV; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ADULT DISEASE; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYMATIC ASSAY; ENZYME ACTIVITY; FEMALE; HIP CIRCUMFERENCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NECK CIRCUMFERENCE; OBESITY; PRIORITY JOURNAL; SALIVA; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; YOUNG ADULT; ENZYMOLOGY; METABOLISM;

ADENOSINE DEAMINASE; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; OBESITY; SALIVA; YOUNG ADULT;

EID: 84930805350     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-1086     Document Type: Article

References (37)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
2. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105:141-50.
3. Ghigliotti G, Barisione C, Garibaldi S, Fabbi P, Brunelli C, Spallarossa P, et al. Adipose tissue immune response: novel triggers and consequences for chronic inflammatory conditions. Inflammation 2014;37:1337-53.
4. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009;276: 5747-54.
5. Kuno M, Seki N, Tsujimoto S, Nakanishi I, Kinoshita T, Nakamura K, et al. Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. Eur J Pharmacol 2006;534:241-9.
6. Haskó G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004;25:33-9.
7. Khemka VK, Bagchi D, Ghosh A, Sen O, Bir A, Chakrabarti S, et al. Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus. Sci World J 2013;2013:404320.
8. Yazbeck R, Howarth GS, Abbott CA. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease Trends Pharmacol Sci 2009;30:600-7.
9. Deacon CF, Carr RD, Holst JJ. DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes. Front Biosci 2008;13:1780-94.
10. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 1999;85: 9-24.
11. Matteucci E, Giampietro O. Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme. Curr Med Chem Rev 2009;16:2943-51.
12. Kobayashi S, Ohnuma K, Uchiyama M, Iino K, Iwata S, Dang NH, et al. Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. Blood 2004;103:1002-10.
13. De Bona KS, Bonfanti G, Cargnelutti LO, Bitencourt PE, da Silva PS, Ceolin R, et al. Lymphocytic enzymes and lipid peroxidation in patients with metabolic syndrome. Clin Biochem 2012;45:1081-5.
14. Bellé LP, Bitencourt PE, De Bona KS, Moresco RN, Moretto MB. Association between HbA1c and dipeptidyl peptidase IV activity in type 2 diabetes mellitus [Letter to the Editor]. Clin Chim Acta 2012;413:1020-1.
15. Al-Rawi NH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 2011;8:22-8.
16. Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, et al. Endothelial-vasoprotective effects of highdensity lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2010;121:110-22.
17. De Almeida PD, Grégio AM, Machado MA, De Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008;9:72-80.
18. Malamud D, Rodriguez-Chavez IR. Saliva as a diagnostic fluid. Dent Clin North Am 2011;55:159-78.
19. Takagi K, Ishikura Y, Hiramatsu M, Nakamura K, Degawa M. Development of a saliva collection device for use in the field. Clin Chim Acta 2013;425:181-5.
20. De Bona KS, Bonfanti G, Bitencourt PE, Cargnelutti LO, da Silva PS, De Lucca L, et al. Butyrylcholinesterase and-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index. Inflammation 2013;36:1539-47.
21. Weiner JS, Lourie JA. Practical human biology. London: Academic Press, 1981.
22. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res 2001;12:S228-33.
23. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000;12:694-701.
24. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005;12:303-7.
25. Sereg, M, Judit T, Attila P, Ibolya V, Péter I, Nikolette S, et al. Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical LCushing's syndrome. Steroids 2011;76:38-42.
26. Nagatsu T, Hino M, Fuyamada H, Hayakawa T, Sakakibara S. New chromogenic substrates for Xprolyl dipeptidyl-aminopeptidase. Anal Biochem 1976;74:466-76.
27. Lapenna GD, Ciofani SD, Pierdomenico MA, Giamberardino MA, Cuccurullo F. Reaction conditions affecting the relationship between thiobarbituric acid reactivity and lipid peroxides in human plasma. Free Radic Biol Med 2001;31:331-5.
28. Vroegrijk IO, van Klinken JB, van Diepen JA, van den Berg SA, Febbraio M, Steinbusch LK, et al. CD36 is important for adipocyte recruitment and affects lipolysis. Obesity (Silver Spring) 2013;21:2037-45.
29. Johansson SM, Lindgren E, Yang JN, Herling AW, Fredholm BB. Adenosine A1 receptors regulate lipolysis and lipogenesis in mouse adipose tissue-interactions with insulin. Eur J Pharmacol 2008;597:92-101.
30. Frühbeck G, Gómez-Ambrosi J, Salvador J. Leptin induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J 2001;15:333-40.
31. Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Med (Hradec Kralove) 2004;47:33-5.
32. Katagiri D, Hamasaki Y, Doi K, Okamoto K, Negishi K, Nangaku M, et al. Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection. J Am Soc Nephrol 2013;24:2034-43.
33. Kos K, Baker AR, Jernas M, Harte AL, Clapham JC, O'Hare JP, et al. DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue. Diabetes Obes Metab 2009;11:285-92.
34. Yu DM, Slaitini L, Gysbers V, Riekhoff AG, Kähne T, Knott HM, et al. Soluble CD26/dipeptidyl peptidase IV enhances human lymphocyte proliferation in vitro independent of dipeptidyl peptidase enzyme activity and adenosine deaminase binding. Scand J Immunol 2011;73:102-11.
35. Lamers D, Famulla S, Wronkowitz N, Hartwig S, Lehr S, Ouwens M, et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 2011;60:1917-25.
36. Mannucci E, Pala L, Ciani S, Bardini G, Pezzatini A, Sposato I, et al. Hyperglycaemia increases dipeptidy peptidase IV activity in diabetes mellitus. Diabetologia 2005;48:1168-72.
37. Kirino Y, Sato Y, Kamimoto T, Kawazoe K, Minakuchi K. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats. Am J Physiol Endocrinol Metab 2011;300:372-9.